Jun. 24 at 7:56 PM
$MTNB On June 23, 2025, Matinas BioPharma Holdings, Inc. held its annual meeting where stockholders approved the 2025 Equity Incentive Plan, which had been previously approved by the board on April 30, 2025. The meeting also saw the election of board members and approval of executive compensation, amendments for reverse stock splits, and an increase in authorized shares, indicating strategic moves to enhance corporate governance and financial flexibility.
